Saturday, March 25, 2023
HomeIndiaGovernanceSun pharma falls after report of fresh whistle-blower complaint

Sun pharma falls after report of fresh whistle-blower complaint

Text Size:

Shares of India’s largest drugmaker fell as much as 13.2 percent.

Mumbai: Sun Pharmaceutical Industries Ltd. plunged to its lowest point in almost six years after a media report that mentioned a new whistle-blower complaint sent to India’s market regulator, alleging corporate governance lapses.

Shares of the nation’s largest drugmaker fell as much as 13.2 percent and were trading 10.5 percent lower at 381.95 rupees a share — the lowest level since February 2013 — at 10:55 a.m in Mumbai. It was also the worst performer on S&P BSE Sensex this year, data compiled by Bloomberg show.

A 172-page complaint sent to the Securities and Exchange Board of India alleges a company that acts as Sun Pharma’s distributor in India, and has been declared as a related party, did 58 billion rupees worth of transactions with a realty firm controlled by one of Sun Pharma’s directors, according to a Jan. 16 report from website

Gaurav Chugh, a spokesman for Sun Pharma, decline to comment when reached by phone. SEBI spokesman N. Hariharan didn’t respond to calls and text messages by Bloomberg seeking comment.

A November report by the Press Trust of India said India’s stock market regulator is likely to reopen an insider trading case against Sun Pharma to probe alleged lapses by some of its promoters and other entities in raising funds oversees. – Bloomberg

Subscribe to our channels on YouTube & Telegram

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

Most Popular